Mass spectrometry in the therapeutic drug monitoring of direct oral anticoagulants. Useful or useless?
J Douxfils, L Pochet, S Lessire, C Vancraeynest… - TrAC Trends in …, 2016 - Elsevier
Direct oral anticoagulants (DOACs) are now widely used in various thromboembolic
diseases. Although routine therapeutic drug monitoring is not required, cumulative evidence …
diseases. Although routine therapeutic drug monitoring is not required, cumulative evidence …
Mass spectrometry in the therapeutic drug monitoring of direct oral anticoagulants. Useful or useless?
J Douxfils, L Pochet, S Lessire, C Vancraeynest… - TrAC Trends in …, 2016 - infona.pl
Direct oral anticoagulants (DOACs) are now widely used in various thromboembolic
diseases. Although routine therapeutic drug monitoring is not required, cumulative evidence …
diseases. Although routine therapeutic drug monitoring is not required, cumulative evidence …
Mass spectrometry in the therapeutic drug monitoring of direct oral anticoagulants. Useful or useless?
J Douxfils, L Pochet, S Lessire… - Trends in Analytical …, 2016 - dial.uclouvain.be
Direct oral anticoagulants (DOACs) are now widely used in various thromboembolic
diseases. Although routine therapeutic drug monitoring is not required, cumulative evidence …
diseases. Although routine therapeutic drug monitoring is not required, cumulative evidence …